Inventor · disambiguated record
Hongfu Lu
Also filed as: LU HONGFU
7 granted patents·6 pending applications·8 citations·filing 2015–2025
75Inventor score
Files withSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD7INSILICO MEDICINE IP LTD4GLAXOSMITHKLINE IP DEV LTD2
Top patents by PatentIndex Score
13 records- 0192US11767312B2Phthalazinone compound, and preparation method therefor and medical use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2023·Granted Sep 26, 2023·6 cites·14 claims
- 0282US12234223B2Phthalazinone compound, and preparation method therefor and medical use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2024·Granted Feb 25, 2025·0 cites·30 claims
- 0379US12195457B2Aromatic ring derivative as immunoregulation and preparation method and application of aromatic ring derivativeSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2019·Granted Jan 14, 2025·2 cites·16 claims
- 0477US2025376463A1Protein degradation agent compound preparation method and applicationSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 0574US2023131252A1Phthalazinone compound, and preparation method therefor and medical use thereofSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0671US12077538B2Diacylglycerol kinase (DGK) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 0768US2024051958A1Diacylglycerol kinase (dgk) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 0861US2025145632A1Pyrimidine Heterocyclic Compound, Preparation Method Thereof and use Thereof in MedicineINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 0957US2025214990A1Diacylglycerol kinase (dgk) alpha inhibitors and uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Application pending·0 cites
- 1056US12441706B2Protein degradation agent compound preparation method and applicationSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 14, 2025·0 cites·31 claims
- 1154US2024101568A1Novel benzazepine spiro derivativeSHANGHAI JEMINCARE PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1245US10336719B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 2, 2019·0 cites·15 claims
- 1336US10106515B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 23, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Hongfu Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →